Imatinib Mesylate 47335-0472-13
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 1, 2016
- Listing Expires
- December 31, 2026
- Application
- ANDA078340
Need to source Imatinib Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Imatinib Mesylate | 100 mg/1 |
Drug Class
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]Cytochrome P450 2D6 Inhibitors [MoA]Cytochrome P450 3A4 Inhibitors [MoA]
Selected Package
47335-0472-13Selected500 TABLET, FILM COATED in 1 BOTTLE (47335-472-13)
Other packages for this product(3)
90 TABLET, FILM COATED in 1 BOTTLE (47335-472-81)
30 TABLET, FILM COATED in 1 BOTTLE (47335-472-83)
100 TABLET, FILM COATED in 1 BOTTLE (47335-472-88)